Visual Performance Investigation of Two Toric Soft Contact Lenses
NCT ID: NCT01858701
Last Updated: 2014-10-22
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
49 participants
INTERVENTIONAL
2013-05-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-Centre Clinical Evaluation of Two Reusable Soft Contact Lenses
NCT02815735
A Clinical Comparison of Two Multifocal Toric Soft Contact Lenses
NCT06438601
Clinical Comparison of Two Daily Disposable Toric Soft Contact Lenses
NCT05483127
Clinical Performance of Two Daily Disposable Toric Soft Contact Lenses
NCT04908488
A Clinical Comparison of Two Soft Toric Contact Lenses
NCT06758089
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AO for Astig / Biofinity Toric
Lotrafilcon B toric contact lenses worn in Period 1, followed by comfilcon A toric contact lenses in Period 2, as randomized. Each product will be worn bilaterally on a daily wear basis for 30 days, removed nightly. A minimum 1-day washout of no contact lens wear will precede each wear period.
Lotrafilcon B toric contact lens
Commercially available, silicone hydrogel contact lens for correction of astigmatism
Comfilcon A toric contact lens
Commercially available, silicone hydrogel contact lens for correction of astigmatism
Biofinity Toric / AO for Astig
Comfilcon A toric contact lenses worn in Period 1, followed by lotrafilcon B toric contact lenses in Period 2, as randomized. Each product will be worn bilaterally on a daily wear basis for 30 days, removed nightly. A minimum 1-day washout of no contact lens wear will precede each wear period.
Lotrafilcon B toric contact lens
Commercially available, silicone hydrogel contact lens for correction of astigmatism
Comfilcon A toric contact lens
Commercially available, silicone hydrogel contact lens for correction of astigmatism
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lotrafilcon B toric contact lens
Commercially available, silicone hydrogel contact lens for correction of astigmatism
Comfilcon A toric contact lens
Commercially available, silicone hydrogel contact lens for correction of astigmatism
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Wears toric soft contact lenses;
* Can be successfully fit with study lenses within the power ranges available;
* Has cylinder of ≥ -0.75 diopter in both eyes;
* Has correctable vision of at least 0.1 (logMAR) or better in each eye at distance with both study lenses;
* Willing and able to wear study lenses on a daily wear basis for at least 5 days a week, minimum 8 hours per day, and attend all study visits;
Exclusion Criteria
* Use of medications for which contact lens wear could be contraindicated;
* Monocular (only 1 eye with functional vision) or fit with 1 lens;
* History of herpetic keratitis, ocular surgery, or irregular cornea;
* Known sensitivity to the diagnostic pharmaceuticals to be used in the study;
* Requires presbyopic correction;
* Use of rewetting/lubricating eye-drops more than twice a day;
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jessie Lemp, MS
Role: STUDY_DIRECTOR
Alcon Research
Lyndon Jones, PhD
Role: PRINCIPAL_INVESTIGATOR
School of Optometry and Vision Science
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P/438/13/L
Identifier Type: -
Identifier Source: secondary_id
A01335
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.